IP Group has returned for a series B round raised by Ieso Digital Health, having initially acquired stakes in the business through its purchase of Touchstone.

Ieso Digital Health, a UK-based digital therapeutics platform, closed a £39m ($53m) series B round yesterday featuring commercialisation firm IP Group.

Morningside led the round, while Sony Innovation Fund, a corporate venturing vehicle for conglomerate Sony, Molten Ventures and Ananda Impact Ventures also participated.

Founded in 2000, Ieso Digital Health has developed artificial intelligence (AI)-equipped digital assessment tools and therapeutics to provide treatment for mental health afflictions such as anxiety and depression.

The company is also seeking regulatory approval for…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).